Arkitekt Ventures

Arkitekt Ventures is an early-stage venture capital firm based in New York, founded in 2017. The firm focuses on investing in the healthcare sector, specifically targeting visionary founders who are developing innovative solutions that enhance human health. Arkitekt Ventures seeks to support projects involving disruptive healthcare delivery models and digital health platforms, as well as applications of advanced technologies such as neurotechnology, bioengineering, quantum computing, and artificial intelligence in medicine. Through its investments, Arkitekt Ventures aims to foster significant advancements in healthcare.

Enke Bashllari

Founder and Managing Director

Pavan Choksi

Partner

14 past transactions

Culina Health

Seed Round in 2022
Culina Health is a personalized nutrition platform that offers tele-nutrition services guided by registered dietitians. The platform aims to assist individuals, particularly those with chronic diseases, by providing accessible and culturally competent nutrition care. By prioritizing individual health needs, Culina Health enables customers to make informed dietary choices and adopt healthier habits, ultimately supporting them in leading a balanced and satisfying life. The company's services are designed to simplify the nutrition care process, making it easier for clients to understand and utilize insurance-covered options for their nutritional needs.

Certify

Seed Round in 2022
CertifyOS is a data intelligence platform that focuses on automating provider licensing and credentialing. It offers an API-first and UI-agnostic system that facilitates real-time verification and credentialing for provider health plan enrollment and sourcing. The platform integrates with numerous primary sources, allowing for efficient monitoring and management of provider networks. By providing a comprehensive suite of services, including licensing, credentialing, and ongoing monitoring, CertifyOS aims to simplify the processes for insurance companies and virtual care providers in managing and scaling their provider networks effectively.

NOVOS

Pre Seed Round in 2021
NOVOS is a brand focused on longevity supplements aimed at promoting longer and healthier lives. The company develops science-based products that are designed to slow the aging process and enhance overall well-being. Its offerings include a range of healthcare drink supplements enriched with anti-aging and longevity properties, featuring ingredients such as nicotinamide riboside, magnesium, fisetin, and pterostilbene. These products are formulated with antioxidants and other functional components that support DNA repair and mitigate DNA damage. By addressing these critical health aspects, NOVOS aims to help consumers improve their mental health, wellness, and overall lifespan.

Connie Health

Series A in 2021
Provider of medical advisory services intended to improve the customer experience in Medicare decision-making. The company offers services through its AI-driven technology platform paired with local Medicare experts, help individuals get the benefit out of their insurance plan, optimize prescription costs, and find healthcare providers in their area, enabling old people to choose their optimal healthcare plans, find the suitable doctors available to them and navigate their plan's benefits.

Connie Health

Pre Seed Round in 2020
Provider of medical advisory services intended to improve the customer experience in Medicare decision-making. The company offers services through its AI-driven technology platform paired with local Medicare experts, help individuals get the benefit out of their insurance plan, optimize prescription costs, and find healthcare providers in their area, enabling old people to choose their optimal healthcare plans, find the suitable doctors available to them and navigate their plan's benefits.

HumanFirst

Seed Round in 2019
HumanFirst, formerly known as Elektra Labs, is a healthcare-security company based in Tyngsboro, Massachusetts, that focuses on enhancing healthcare operations in home settings. Established in 2017, the company has developed a digital measures platform called Atlas, which streamlines the evaluation and implementation of connected technologies for collecting behavioral and physiological data. HumanFirst caters to a diverse clientele, including leading organizations involved in decentralized clinical trials and virtual care. Notably, 22 of the 25 largest pharmaceutical companies globally have utilized the HumanFirst platform to assess and facilitate the deployment of health technology products. The company provides command center and infrastructure solutions that ensure the reliability and trustworthiness of telehealth operations, matching the standards typically found in hospitals and laboratories.

Parsley Health

Series B in 2019
Parsley Health is a new kind of healthcare service that integrates technology, nutrition, wellness and prevention into cutting-edge primary care. The company was founded in 2016 by Dr. Robin Berzin, M.D., a Columbia-trained physician, digital health expert and leader in functional medicine. Parsley clinics are currently open in Los Angeles, New York City and San Francisco. Learn more at www.parsleyhealth.com

Tia

Seed Round in 2019
At Tia, we believe that the healthcare system was not built with women in mind. Today, considering that women control 80% of healthcare dollars in the U.S., Tia is seizing the opportunity to build a new, distinctly female model of care digitally and physically. Tia is backed by leading healthcare and consumer funds, including Torch Capital, Define Ventures, Homebrew, Threshold Ventures, and Acme Ventures.

Paradromics

Seed Round in 2018
Paradromics, Inc. is focused on developing brain-machine interfaces that facilitate data transmission between the brain and machines, primarily targeting the treatment of neurodegenerative diseases. The company creates implantable systems capable of decoding complex neural recordings into data streams, which can be utilized by various neural prostheses. Its technology emphasizes high-volume, bidirectional data streaming, allowing patients with neurological disorders to reconnect with their environment and compensate for lost biological connectivity. Founded in 2015 and headquartered in Austin, Texas, Paradromics also offers applications to support its product suite, aiming to enhance the quality of life for individuals with disabilities.

BehaVR

Seed Round in 2018
BehaVR, LLC is a company based in Elizabethtown, Kentucky, that specializes in developing digital therapeutics for behavioral health through a virtual reality platform. Established in 2016, BehaVR focuses on enhancing practices and treatments within the healthcare sector, particularly at the intersection of behavioral health and chronic disease management. The company aims to build skills such as stress resilience, emotional regulation, and self-efficacy, which are essential for helping individuals cope with their health conditions, adhere to care plans, and ultimately improve their overall well-being.

Cake

Seed Round in 2017
Cake LLC is a Boston-based company that offers guidance, planning, and consulting services related to end-of-life preferences through its application. This platform allows users to create a secure online document detailing their instructions for various aspects of mortality, including healthcare, funerals, financial, and legal matters. Cake serves as a comprehensive resource, featuring over 1,400 articles and interactive planning tools designed to assist individuals in navigating the complexities of end-of-life decisions. With a monthly reach of over 1.5 million unique visitors, Cake collaborates with various organizations in the healthcare and financial sectors, providing essential support for users looking to curate their digital legacy and make meaningful choices regarding their mortality.

Darmiyan

Seed Round in 2017
Darmiyan, Inc. is a company that specializes in the development of diagnostic software aimed at the early detection and monitoring of Alzheimer's disease and other neurodegenerative disorders. Based in San Francisco and founded in 2014, the company offers BrainSee, a Software as a Service platform that utilizes non-invasive brain MRI scans to produce detailed brain maps. This innovative tool quantifies neurodegeneration in individual brain voxels and generates a summary score reflecting brain health and the risk of cognitive decline. BrainSee operates using proprietary technology, referred to as The Virtual Microscope, which provides insights into brain cell distortion before clinical symptoms manifest. The algorithm has undergone successful third-party validation in the US and Canada, demonstrating its accuracy in predicting mild cognitive impairment. By leveraging advanced medical imaging and artificial intelligence, Darmiyan aims to enhance early diagnosis and intervention for patients with neurodegenerative diseases.

Medivis

Seed Round in 2017
Medivis is a developer of advanced medical imaging technology that utilizes augmented reality and artificial intelligence to enhance surgical operations. The company's innovative platform enables physicians to overlay holographic images directly onto patients during procedures, facilitating precise decision-making in the operating room. By integrating these technologies, Medivis aims to improve surgical outcomes and streamline the workflow for healthcare professionals, ultimately advancing the field of surgical navigation.

Parsley Health

Seed Round in 2017
Parsley Health is a new kind of healthcare service that integrates technology, nutrition, wellness and prevention into cutting-edge primary care. The company was founded in 2016 by Dr. Robin Berzin, M.D., a Columbia-trained physician, digital health expert and leader in functional medicine. Parsley clinics are currently open in Los Angeles, New York City and San Francisco. Learn more at www.parsleyhealth.com
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.